Page last updated: 2024-08-17

n,n-dimethyltryptamine and Neurodegenerative Diseases

n,n-dimethyltryptamine has been researched along with Neurodegenerative Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bari, F; Berkecz, R; Cozzi, NV; Dvorácskó, S; Farkas, AE; Farkas, E; Frank, R; Frecska, E; Hantosi, D; Kecskés, S; Körmöczi, T; Krizbai, IA; Menyhárt, Á; Szabó, Í; Tömböly, C; Varga, VÉ	1

Other Studies

1 other study(ies) available for n,n-dimethyltryptamine and Neurodegenerative Diseases

Article	Year
N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain. Neuropharmacology, 2021, 07-01, Volume: 192 Topics: Animals; Brain; Brain Ischemia; Cortical Spreading Depression; Dose-Response Relationship, Drug; Male; N,N-Dimethyltryptamine; Neurodegenerative Diseases; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor	2021

Article

Year

N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain.

Neuropharmacology, 2021, 07-01, Volume: 192

Topics: Animals; Brain; Brain Ischemia; Cortical Spreading Depression; Dose-Response Relationship, Drug; Male; N,N-Dimethyltryptamine; Neurodegenerative Diseases; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor

2021